A Dietary Intervention (Soy Soft Pretzels) for Reducing Chronic Inflammation in Obese Individuals
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT07650409
- Status
- Active Not Recruiting
Conditions
- Colorectal Carcinoma
- Obesity-Related Malignant Neoplasm
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 49 Years
- Healthy Volunteers
- Accepted
Interventions
- Biospecimen Collection — PROCEDUREUndergo collection of blood and urine samples
- Dietary Intervention — OTHERConsume SSPs
- Dietary Intervention — OTHERConsume WPs
- Questionnaire Administration — OTHERAncillary studies
Study Details
This clinical trial compares the effects of soy soft pretzels versus wheat pretzels on inflammatory markers in individuals with obesity. Obesity is a serious public health problem that can lead to chronic inflammation, which is associated with many negative health conditions and some types of cancer. Soy versus wheat pretzels may be processed by the body differently, and the components in these pretzel snacks may be helpful for reducing inflammation. Soy soft pretzels are made with soybeans, which contain many natural chemicals that may be beneficial to human health, such as isoflavones. Existing research has suggested that diets enriched with isoflavones may help reduce inflammation. However, the relationship between soy-rich diets and the immune systems of obese individuals is not well understood. This trial may help researchers determine whether soy soft pretzels are useful for lowering markers of chronic inflammation, compared to wheat pretzels, in individuals with obesity.
Key Dates
- Start date
- Jun 1, 2025
- Status verified
- Jun 2026
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- PREVENTION
Arms
- Experimental: Arm I (SSP, WP)Patients consume 8 SSP bites BID for 14 days (days 1-14) and then begin a two-week washout period (days 15-28). Following the washout period, patients consume WP bites BID for 14 days (days 28-42). Patients also undergo collection of blood and urine samples on study.
- Experimental: Arm II (WP, SSP)Patients consume 8 WP bites BID for 14 days (days 1-14) and then begin a two-week washout period (days 15-28). Following the washout period, patients consume SSP bites BID for 14 days (days 28-42). Patients also undergo collection of blood and urine samples on study.
- Experimental: Arm III (WP, SSP)Patients receive intervention as in Arm I. Patients also undergo collection of blood and urine samples on study.
Primary Outcome Measure
Differences in chronic inflammatory biomarkers [ Time Frame: Up to 42 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | - |
Find similar trials in Columbus, OH
Related Studies
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- Testing for Safety and Colorectal Cancer Preventive Effects of ONC201PHASE1 · Recruiting · National Cancer Institute (NCI) · Ann Arbor, Michigan
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesPHASE1/PHASE2 · Recruiting · Institut de Recherches Internationales Servier · Gilbert, Arizona
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruiting · Wake Forest University Health Sciences · Fairbanks, Alaska